In his new position, Dr. Slotkin will be assisting with regulatory submissions, clinical and medical reporting and clinical trial monitoring. He will also consult with investors and potential collaborators, physicians and licensing partners.
Dr. Slokin has an expertise in complex spinal surgery, minimally invasive spinal surgery, spinal oncology and brain tumor surgery. During his career, he has participated in research on regeneration and plasticity after spinal cord injury, among other projects.
Read the release about Dr. Jonathan Slotkin’s appointment.
Related Articles on InVivo Therapeutics:
InVivo Therapeutics Partners With The Miami Project to Cure Paralysis
InVivo Therapeutics Reports $1.28M Net Loss in Q1
8 Recent Orthopedic and Spine Device Company Partnerships and Acquisitions
